Gounder Culls the News, From Ticks and AI to Who Might Lead CDC
KFF Health News journalists made the rounds on national or local media recently to discuss topical stories. Here’s a collection of their appearances.
CDC
1 - 20 of 548 Results
-
A New CDC Nominee, Again
Episode 442President Donald Trump this week nominated a former deputy surgeon general who has expressed support for vaccines to lead the Centers for Disease Control and Prevention. Considered a more traditional fit for the job, Erica Schwartz would be the agency’s fourth leader in roughly a year, should she be confirmed by the Senate. And Health […]
-
As US Birth Rate Falls, Feds’ Response May Make Pregnancy More Dangerous
A funding notice for Title X shifts the program’s emphasis from contraception to fertility, family formation, and addressing conditions that could cause infertility, including endometriosis. Experts say these priorities overlook key demographic trends, epidemiology, prevention of unwanted pregnancies, and the nation's high maternal mortality.
A Headless CDC
Episode 439The Trump administration faces the challenge of naming a new director of the Centers for Disease Control and Prevention who can both satisfy the Make America Healthy Again movement and get confirmed by the Senate. Meanwhile, a new Senate bill to rescind the approval of the abortion pill mifepristone is again elevating the abortion debate, which some Republicans would prefer to stay on the back burner until after the midterms. Shefali Luthra of The 19th, Lizzy Lawrence of Stat, and Rachel Cohrs Zhang of Bloomberg News join KFF Health News’ Julie Rovner to discuss the news. Also this week, Rovner interviews Georgetown University Law Center’s Katie Keith about the state of the Affordable Care Act on its 16th anniversary.
-
CDC’s Acting Chief Promises a Return to Stability in a Tumultuous Moment
Jay Bhattacharya, head of the National Institutes of Health and interim leader of the Centers for Disease Control and Prevention, told the CDC staff, “I know that it has been such a difficult year.”
-
Demoralized CDC Workforce Reels From Year of Firings, Funding Cuts, and a Shooting
Thousands of employees are gone and last summer’s shooting resonates still at the Centers for Disease Control and Prevention headquarters and among the large public health community in Atlanta.
-
Newsom Picks a Dogfight With Trump and RFK Jr. on Public Health
Scientists are cheering California Gov. Gavin Newsom as he builds a public health bulwark against health secretary Robert F. Kennedy Jr.’s anti-vaccine stance and President Donald Trump’s withdrawal from the World Health Organization. Still, federal cuts have sapped morale and left local health departments less prepared for outbreaks.
By Angela Hart -
This Doctor-Senator Who Backed RFK Jr. Now Faces a Fight for His Job — And His Legacy
A year after Sen. Bill Cassidy, a Louisiana Republican, warily cast the vote ensuring Robert F. Kennedy Jr.’s ascension to Health and Human Services secretary, his life’s work — in medicine and in politics — is unraveling.
By Amanda Seitz -
Readers Lean On Congress To Solve Crises in Research and Rehab
KFF Health News gives readers a chance to comment on a recent batch of stories.
-
Trump’s Covid Views Don’t Track With Reality That Recent Studies Suggest
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
-
Trump Policies at Odds With Emerging Understanding of Covid’s Long-Term Harm
Studies increasingly offer insights into the health risks and burdens faced by people who have had covid infections. Meanwhile, the Trump administration has narrowed covid vaccine recommendations and cut research.
-
Journalists Mine News for Insights on Tylenol, Obamacare Credits, and Rural Health Funding
KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a collection of their appearances.
-
As US Is Poised To Lose Measles-Free Status, RFK Jr.’s New CDC Deputy Downplays Its Significance
Measles is at a 30-year high in the U.S., but technicalities may stave off the loss of the nation’s measles elimination status.
By Amy Maxmen -
Native Americans Are Dying From Pregnancy. They Want a Voice To Stop the Trend.
Native American women face higher rates of death than other demographics. In response, Native Americans have been working with state and federal officials to boost tribal participation and leadership in maternal mortality review committees to better track and address pregnancy-related deaths.
-
Vaccines Are Helping Older People More Than We Knew
Many shots seem to have “off-target” benefits, such as lowering the risk of dementia, studies have found.
By Paula Span -
RFK Jr.’s MAHA Movement Has Picked Up Steam in Statehouses. Here’s What To Expect in 2026.
“Make America Healthy Again” policies driven by HHS Secretary Robert F. Kennedy Jr. have made major strides in state legislatures, with food additives among the most common targets. The trend is expected to continue this year.
-
Vaccines Jettisoned by CDC Safeguarded Millions From Disease
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
By Arthur Allen and Jackie Fortiér -
The CDC Just Sidelined These Childhood Vaccines. Here’s What They Prevent.
The CDC is recommending fewer childhood vaccines, although the ones it has jettisoned from the recommended schedule have successfully battled serious illness for years. Experts warn that if vaccine uptake falls, millions could be hospitalized — or worse — as a result of preventable diseases.
By Arthur Allen and Jackie Fortiér -
Inside the FDA’s Vaccine Uproar
An internal email claiming covid vaccines killed children triggered a formal response from a dozen past FDA commissioners. The email, sent by the head of the Center for Biologics Evaluation and Research, outlines a framework that could have significant impact on the nation’s vaccine policies.
-
Vaccine Panel’s Hepatitis B Vote Signals Further Turbulence for Immunization Policy, Public Trust
Clinicians and epidemiologists warn the decision to no longer recommend the birth dose of the hepatitis B vaccine could unravel decades of progress and expose newborns to a deadly, preventable disease.